|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/145 | |
| C12Q 1/70 |
| (11) | Number of the document | 2471551 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12157945.2 |
| Date of filing the European patent application | 2005-09-09 | |
| (97) | Date of publication of the European application | 2012-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 04255471 | 2004-09-09 | EP |
| (72) |
Gregersen, Jens Peter, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Decreasing potential iatrogenic risks associated with influenza vaccines |
| Decreasing potential iatrogenic risks associated with influenza vaccines |